By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Breckenridge Pharmaceutical, Inc. 

1141 S. Rogers Circle
Suite 3
Boca Raton  Florida  33487  U.S.A.
Phone: 800-367-3395 Fax: 561-989-9747


SEARCH JOBS


Industry
Pharmaceutical






Company News
Breckenridge Pharmaceutical, Inc. Announces Final Approval For Omeprazole Delayed-Release Capsules 7/6/2017 6:35:06 AM
Breckenridge Pharmaceutical, Inc. Signs Multi-Product Agreement With Sam Chun Dang Pharm. Co. Ltd. 6/30/2017 7:34:00 AM
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Azacitidine For Injection (Vidaza) 6/26/2017 10:25:59 AM
Breckenridge Pharmaceutical, Inc. Announces Launch Of Desvenlafaxine XR Tablets (Generic For Pristiq) 3/1/2017 7:28:45 AM
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Bendamustine Hcl Powder For IV (Treanda) 1/9/2017 7:04:49 AM
Breckenridge Pharmaceutical, Inc. Signs Marketing Agreement With Gland Pharma For Seven Injectable Products 12/6/2016 6:42:03 AM
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Armodafinil Tablets (CIV) In 50mg, 150mg And 250 Mg Strengths (Nuvigil) 11/29/2016 6:29:00 AM
Breckenridge Pharmaceutical, Inc. Announces Entry Into Injectable Market With The Immediate Launch Of Methylergonovine Maleate Injection 11/10/2016 3:18:10 PM
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Lacosamide Tablets (Vimpat) 5/4/2016 6:42:41 AM
Breckenridge Pharmaceutical, Inc. Announces Approval For Gabapentin Oral Solution 3/18/2016 6:30:29 AM
1234567
//-->